Cycle Pharmaceuticals is seeking a Senior Clinical Study Manager to lead operational delivery of Phase 3 and Phase 4 trials in rare diseases from our Cambridge office on a hybrid basis (minimum 3 days in the office).
You will own studies from feasibility through final clinical study report, ensuring timelines, budgets and high-quality regulatory compliance. This is a broad, hands-on role with cross‑functional collaboration and potential for future leadership opportunities.
#J-18808-Ljbffr
Senior Clinical Study Manager – Rare Diseases (Phase 3, Hybrid) in Cambridge employer: Cycle Pharmaceuticals
Cycle Pharmaceuticals Ltd is an exceptional employer located in the vibrant city of Cambridge, offering a dynamic work culture that fosters innovation and collaboration in the field of rare diseases. Employees benefit from a supportive environment that prioritises professional growth, with opportunities to lead impactful projects that align with FDA standards. The hybrid work model enhances work-life balance, making it an ideal place for those seeking meaningful and rewarding careers in healthcare.
